BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 18252951)

  • 1. Kisspeptin-13 inhibits insulin secretion without affecting glucagon or somatostatin release: study in the perfused rat pancreas.
    Silvestre RA; Egido EM; Hernández R; Marco J
    J Endocrinol; 2008 Feb; 196(2):283-90. PubMed ID: 18252951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelationship among insulin, glucagon and somatostatin secretory responses to exendin-4 in the perfused rat pancreas.
    Silvestre RA; Rodríguez-Gallardo J; Egido EM; Marco J
    Eur J Pharmacol; 2003 May; 469(1-3):195-200. PubMed ID: 12782202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exendin-4 dose-dependently stimulates somatostatin and insulin secretion in perfused rat pancreas.
    Egido EM; Silvestre RA; Hernández R; Marco J
    Horm Metab Res; 2004 Sep; 36(9):595-600. PubMed ID: 15486809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of insulin and somatostatin secretion and stimulation of glucagon release by homologous galanin in perfused rat pancreas.
    Miralles P; Peiró E; Dégano P; Silvestre RA; Marco J
    Diabetes; 1990 Aug; 39(8):996-1001. PubMed ID: 1695589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tungstate stimulates insulin release and inhibits somatostatin output in the perfused rat pancreas.
    Silvestre RA; Egido EM; Hernández R; Marco J
    Eur J Pharmacol; 2005 Sep; 519(1-2):127-34. PubMed ID: 16126195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion.
    Egido EM; Rodriguez-Gallardo J; Silvestre RA; Marco J
    Eur J Endocrinol; 2002 Feb; 146(2):241-4. PubMed ID: 11834435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for kisspeptin in islet function.
    Hauge-Evans AC; Richardson CC; Milne HM; Christie MR; Persaud SJ; Jones PM
    Diabetologia; 2006 Sep; 49(9):2131-5. PubMed ID: 16826407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homologous pancreastatin inhibits insulin secretion without affecting glucagon and somatostatin release in the perfused rat pancreas.
    Peiró E; Dégano P; Miralles P; Silvestre RA; Marco J
    Regul Pept; 1991 Jul; 34(3):159-67. PubMed ID: 1681569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of galanin on hormone secretion from the in situ perfused rat pancreas and on glucose production in rat hepatocytes in vitro.
    Silvestre RA; Miralles P; Monge L; Moreno P; Villanueva ML; Marco J
    Endocrinology; 1987 Jul; 121(1):378-83. PubMed ID: 2439313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulatory effect of xenin-8 on insulin and glucagon secretion in the perfused rat pancreas.
    Silvestre RA; Rodríguez-Gallardo J; Egido EM; Hernández R; Marco J
    Regul Pept; 2003 Aug; 115(1):25-9. PubMed ID: 12873795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 26RFa, a novel orexigenic neuropeptide, inhibits insulin secretion in the rat pancreas.
    Egido EM; Hernández R; Leprince J; Chartrel N; Vaudry H; Marco J; Silvestre RA
    Peptides; 2007 Apr; 28(4):725-30. PubMed ID: 16777265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of PHI on hormonal secretion from perfused rat pancreas.
    Szecówka J; Tendler D; Efendić S
    Am J Physiol; 1983 Oct; 245(4):E313-7. PubMed ID: 6137956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
    Johnson DG; Ensinck JW; Koerker D; Palmer J; Goodner CJ
    Endocrinology; 1975 Feb; 96(2):370-4. PubMed ID: 1089535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulphonylurea (glubenclamide) enhances somatostatin and inhibits glucagon release induced by arginine.
    Efendić S; Enzmann F; Nylén A; Uvnäs-Wallensten K; Luft R
    Acta Physiol Scand; 1980 Mar; 108(3):231-3. PubMed ID: 6103639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.
    Singh V; Brendel MD; Zacharias S; Mergler S; Jahr H; Wiedenmann B; Bretzel RG; Plöckinger U; Strowski MZ
    J Clin Endocrinol Metab; 2007 Feb; 92(2):673-80. PubMed ID: 17105845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of vasoactive intestinal polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas.
    Szecówka J; Sandberg E; Efendić S
    Diabetologia; 1980 Aug; 19(2):137-42. PubMed ID: 6106616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by somatostatin of glucagon and insulin release from the perfused rat pancreas in response to arginine, isoproterenol and theophylline: evidence for a preferential effect on glucagon secretion.
    Gerich JE; Lovinger R; Grodsky GM
    Endocrinology; 1975 Mar; 96(3):749-54. PubMed ID: 1116481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of K+ and arginine on insulin, glucagon, and somatostatin release from the in vitro perfused rat pancreas.
    Frankel BJ; Heldt AM; Grodsky GM
    Endocrinology; 1982 Feb; 110(2):428-31. PubMed ID: 6120069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas.
    Egido EM; Hernández R; Marco J; Silvestre RA
    Regul Pept; 2009 Jan; 152(1-3):61-6. PubMed ID: 18773927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of leptin on insulin, glugacon and somatostatin secretion in the perfused rat pancreas.
    Silvestre RA; Rodríguez-Gallardo J; Egido EM; Marco J
    Horm Metab Res; 2001 Apr; 33(4):207-12. PubMed ID: 11383923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.